Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Lexagene Hldgs Inc (LXXGF)

Lexagene Hldgs Inc (LXXGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
LexaGene Reduces Time-to-Result by ~35% Globe Newswire - Wed Aug 10, 2022

BEVERLY, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to Employees Globe Newswire - Fri Jul 29, 2022

BEVERLY, Mass., July 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections Globe Newswire - Wed Jul 27, 2022

BEVERLY, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections Globe Newswire - Tue Jul 5, 2022

BEVERLY, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin Globe Newswire - Fri Jul 1, 2022

BEVERLY, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene Announces Management Cease Trade Order Globe Newswire - Thu Jun 30, 2022

BEVERLY, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”) announces, further to...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings Globe Newswire - Tue Jun 28, 2022

BEVERLY, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”) announces that it has...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health Globe Newswire - Wed May 25, 2022

BEVERLY, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene Successfully Completes CRADA with US Army Globe Newswire - Tue May 3, 2022

BEVERLY, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)
LexaGene to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021 ACCESS Newswire - Tue Aug 17, 2021

BEVERLY, MA / ACCESSWIRE / August 17, 2021 / LexaGene Holdings, Inc., (OTCQB:LXXGF)(TSXV:LXG) a molecular diagnostics company developing automated rapid polymerase chain reaction (PCR) testing solutions...

LXG.VN : 0.105 (-19.23%)
LXXGF : 0.0806 (-16.48%)

Barchart Exclusives

As NetApp Expands Its Relationship With Google Cloud, Should You Buy, Sell, or Hold NTAP Stock? Barchart - 1 hour ago
Does this AI-driven push by NetApp make the stock a buy now, or start thinking about taking profits? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.